OTLK Stock Summary and Trading Ideas (Outlook Therapeutics | NASDAQ:OTLK)

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

Outlook Therapeutics trades on the NASDAQ stock market under the symbol OTLK.

As of September 4, 2026, OTLK stock price climbed to $0.67 with 6,231,649 million shares trading.

OTLK has a beta of 2.90, meaning it tends to be more sensitive to market movements. OTLK has a correlation of 0.03 to the broad based SPY ETF.

OTLK has a market cap of $161.74 million. This is considered a Micro Cap stock.

Last quarter Outlook Therapeutics reported $9,000 in Revenue and -$.09 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.01.

In the last 3 years, OTLK traded as high as $18.00 and as low as $.16.

The top ETF exchange traded funds that OTLK belongs to (by Net Assets): VTI, VXF.

OTLK has underperformed the market in the last year with a return of -25.0%, while the SPY ETF gained +19.8%. In the last 3 month period, OTLK fell short of the market, returning -16.1%, while SPY returned +2.0%. However, in the most recent 2 weeks OTLK has outperformed the stock market by returning +3.0%, while SPY returned +0.6%.

OTLK support price is $.60 and resistance is $.70 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OTLK shares will trade within this expected range on the day.